The effects of lithium in vitro and ex vivo on adenylate cyclase in brain are exerted by distinct mechanisms

Neuropharmacology. 1989 Mar;28(3):307-11. doi: 10.1016/0028-3908(89)90108-1.

Abstract

The effects of lithium on basal and forskolin-stimulated activity of adenylate cyclase in membrane preparations from cerebral cortex of the rat have been studied. Chronic treatment with lithium, yielding a level of lithium in serum of 0.71 +/- 0.18 mmol/l, reduced forskolin-stimulated activity in total homogenates but exerted no effect on the basal activity. Lithium in vitro, at 2 and 10 mM, did not influence the basal enzyme activity in membranes from either control or lithium-treated animals. The sensitivity of forskolin-stimulated adenylate cyclase to lithium in vitro was unaltered after chronic treatment and the in vitro and ex vivo effects of lithium on this parameter were additive. The inhibitory ex vivo effect of lithium was not antagonized by increasing concentrations of magnesium and the inhibitory effect of lithium ex vivo was still persistent after washing of the membranes. The present results indicate that lithium exerts its ex vivo effect on the activated cyclase, independently of the in vitro effect. Both effects may, however, contribute to the in vivo effect of lithium during chronic treatment.

MeSH terms

  • Adenylyl Cyclases / metabolism*
  • Animals
  • Brain / drug effects
  • Brain / enzymology*
  • Cerebral Cortex / drug effects
  • Cerebral Cortex / enzymology
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism
  • Lithium / pharmacology*
  • Magnesium / pharmacology
  • Male
  • Membranes / enzymology
  • Membranes / metabolism
  • Rats
  • Rats, Inbred Strains

Substances

  • Colforsin
  • Lithium
  • Cyclic AMP
  • Adenylyl Cyclases
  • Magnesium